Session » Abstracts: Systemic Sclerosis and Related Disorders – Clinical I: Trials and Therapeutics
- 3:00PM-4:30PM
-
Abstract Number: 0518
Changes in Skin Fibroblast Polarization Gene Expression Herald Clinical Improvement in Early, Diffuse Cutaneous Systemic Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 0522
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis from EUSTAR
- 3:00PM-4:30PM
-
Abstract Number: 0520
Combination Therapy of Mycophenolate Mofetil and Pirfenidone vs. Mycophenolate Alone: Results from the Scleroderma Lung Study III
- 3:00PM-4:30PM
-
Abstract Number: 0521
Examination of Differential Response to Treatment with Mycophenolate Mofetil in Black and White Patients with Systemic Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 0519
Myeloablation Followed by Hematopoietic Stem Cell Transplantation Leads to Long-term Normalization of Systemic Sclerosis Molecular Signatures